Legend Biotech (LEGN) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Legend Biotech Corporation held its annual general meeting on October 21, 2024, where shareholders approved key resolutions, including the re-election of directors and an increase in shares for their 2020 Restricted Shares Plan. The meeting witnessed robust participation with over 95% of shares represented, underscoring strong shareholder engagement. These decisions highlight ongoing confidence in Legend Biotech’s strategic direction.
For further insights into LEGN stock, check out TipRanks’ Stock Analysis page.
